Danielle M. Sloane

More Losses Than Gains? OIG Declines To Approve Certain Medicare Advantage Gainsharing Arrangements In Advisory Opinion 24-08

CMS Finalizes New Mandatory Value-Based Payment Initiative: The Transforming Episode Accountability Model

Danielle Sloane And Morgan Tandy Examine Recent Court Cases Regarding Labs

The End Of An Era? FDA Finalizes LDT Rule But Grandfathers Many Existing LDTs

Danielle Sloane And Morgan Tandy Outline Recent Enforcement Actions And Court Cases Involving Labs

CMS Proposes New Mandatory Value-Based Payment Initiative: The Transforming Episode Accountability Model

Labs Take Note: New OIG Opinion Highlights That Fair Market Value Per Test Payments Can Still Violate The Anti-Kickback Statute

Extension Extended: DEA Continues Telemedicine Prescription Flexibilities Through 2024

FDA Takes Definitive Step Toward The Regulation Of LDTs

The No Surprises Act Passed And (Surprise!) Healthcare Providers Are Leery Of Its Impact